Erythema Nodosum Manifestation Post COVID-19 Vaccine: A Case Report
- 1 Department of Dermatology and Venereology, Ibn Rochd University Hospital, Casablanca, Morocco
- 2 Department of Dermatology and Venereology, Ibn Rochd University Hospital, Casablanca, Morocco
- 3 Department of Dermatology and Venereology, Ibn Rochd University Hospital, Casablanca, Morocco
- 4 Pathology Center Ibn Zohr, Casablanca, Morocco
Abstract
Erythema nodosum (EN) is a delayed hypersensitivity response that may be triggered by a range of conditions, including infections and vaccines. Rare cases of EN caused by COVID-19 were recently reported but none due to COVID-19 vaccines were documented. We report here a case of EN occurring after COVID-19 vaccination. Patient presented with painful nodular lesions of all 4 limbs, evolving for one month. These lesions appeared 48 h after the second dose of COVID-19 vaccination. The patient reported no recent infectious episodes. The physical examination found numerous, erythematous dermohypodermatitis knots with no palpable adenopathy. Some were regressive according to biligenesis shades. Biology and radiology findings eliminated other common causes of this dermatosis. The skin biopsy was done and suggested EN. The final diagnosis was post COVID-19 vaccine EN. Patient received a symptomatic treatment and had a slight improvement of the lesions 10 days after diagnosis. Physicians should be aware of the side effects of the vaccine including skin manifestations, especially since more people are bound to be vaccinated.
- Schwartz, R.A. and Nervi, S.J. (2007) Erythema Nodosum: A Sign of Systemic Disease. American Family Physician, 75, 695-700.
- Ordieres-Ortega, L., Toledo-Samaniego, N., Parra-Virto, A., Fernández-Carracedo, E., Lavilla-Olleros, C. and Demelo-Rodríguez, P. (2020) Atypical Erythema Nodosum in a Patient with COVID-19 Pneumonia. Dermatologic Therapy, 33, e13658. https://doi.org/10.1111/dth.13658
- Suter, P., Mooser, B. and Thien, H.P. (2020) Erythema Nodosum as a Cutaneous Manifestation of COVID-19 Infection. BMJ Case Reports, 13, e236613. https://doi.org/10.1136/bcr-2020-236613
- Cribier, B., Caille, A., Heid, E. and Grosshans, E. (1998) Erythema Nodosum and Associated Diseases. A Study of 129 Cases. International Journal of Dermatology, 37, 667-672. https://doi.org/10.1046/j.1365-4362.1998.00316.x
- Blake, T., Manahan, M. and Rodins, K. (2014) Erythema Nodosum—A Review of an Uncommon Panniculitis. Dermatology Online Journal, 20, 22376. https://doi.org/10.5070/D3204022376
- Requena, L. and Yus, E.S. (2008) Erythema Nodosum. Dermatologic Clinics, 26, 425-438. https://doi.org/10.1016/j.det.2008.05.014
- Rachadi, H., Ramli, I., Senouci, K., Hassam, B. and Ismaili, N. (2015) érythème noueux induit par l’imatinib : Un cas confirmé par une épreuve de réintroduction positive. Annales de Dermatologie et de Vénéréologie, 142, S694. https://doi.org/10.1016/j.annder.2015.10.568
- Goolsby, P.L. (1989) Erythema Nodosum after Recombivax HB Hepatitis B Vaccine. The New England Journal of Medicine, 321, 1198-1199. https://doi.org/10.1056/NEJM198910263211717
- Thomson, B.J. and Nuki, G. (1985) Erythema Nodosum Following Typhoid Vaccination. Scottish Medical Journal, 30, 173. https://doi.org/10.1177/003693308503000310
- Doffoel-Hantz, V., Hantz, S., Souyri, N., Nouaille, Y., Bédane, C. and Sparsa, A. (2009) Erythème Noueux Induit par le Gardasil®. La Revue de Médecine Interne, 30, S131-S132. https://doi.org/10.1016/j.revmed.2009.03.291
- Longueville, C., Doffoel-Hantz, V., Hantz, S., Souyri, N., Nouaille, Y., Bédane, C., et al. (2012) érythème Noueux Induit par le Gardasil®. La Revue de Médecine Interne, 33, e17-e18. https://doi.org/10.1016/j.revmed.2011.02.013
- Wang, J., Peng, Y., Xu, H., Cui, Z. and Williams, R.O. (2020) The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech, 21, Article No. 225. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405756/ https://doi.org/10.1208/s12249-020-01744-7